What Is Treatment-Resistant Depression?
Once you’re diagnosed as having depression, you count on treatments to help you manage symptoms like anxiety, despair, and lack of energy. Yet, what should you do if traditional antidepressants don’t help or make your symptoms more unbearable? If you have previously turned to multiple treatments and still grapple with depression, you might have Treatment-Resistant Depression (TRD). Learn more about this condition and see if you or a loved one has Treatment-Resistant Depression.
How Are Individuals Diagnosed With Treatment-Resistant Depression In Monmouth Junction?
Treatment-resistant depression refers to patients with major depressive disorder (MDD) who have tried two or more oral antidepressants to the prescribed dose and duration without relief. While you could detect short-lived elevations in mood, they are usually replaced by additional symptoms. You might even realize that your bouts of depression are longer and more severe.
If antidepressants don’t work for you, you’re not alone. According to the results of one study, between 29% and 46% of participants didn’t respond to oral antidepressants.
What Are The Symptoms Of Treatment-resistant Depression?
TRD is form of Major Depressive Disorder. Therefore, the symptoms of treatment-resistant depression are well known, but you don’t get relief from traditional antidepressants. These symptoms often include:
- Continuing sadness or hopelessness
- No interest or delight in activities
- Changes in weight or appetite
- Sleep difficulties like insomnia or lethargy
- Feeling bad about oneself.
- Difficulty paying attention
- Phantom pain in joints
- Self-harm
- Recurrent thoughts of death or suicide
It's essential to understand that the consistency and intensity of these symptoms, despite treatment, make TRD distinct from other kinds of depression. In addition, addressing TRD typically demands a more multi-faceted kind of depression treatment near Monmouth Junction, including potentially a combination of prescriptions and therapy.
SPRAVATO Sanctioned For Treatment-Resistant Depression
SPRAVATO is the first FDA-authorized nasal spray to treat individuals age 18 and over with treatment-resistant depression. Esketamine is the active ingredient and is thought to reduce symptoms by influencing certain brain circuits. In a clinical analysis, individuals who took Spravato and an oral antidepressant experienced a more effective reduction in depressive symptoms after four weeks than those who were provided a placebo and an antidepressant.
SPRAVATO is administered while being closely monitored by medical specialists at a facility authorized by the Risk Evaluation and Mitigation Strategy (REMS) program. A thorough examination of your medical records is needed prior to use. Serious side effects may occur, such as feelings of detachment and sedation, and patients must be watched for two hours after treatment.
Find Help For Treatment-resistant Depression In Monmouth Junction At The Counseling Center at Monmouth Junction
Treatment-resistant depression can bring on an additional level of anxiety with feelings that your condition may not get better. However, a new strategy for medication, therapy, and care will help you overcome TRD. The Counseling Center at Monmouth Junction is here to help. We supply an array of services for treatment-resistant depression and are a certified SPRAVATO treatment provider. Find help now by contacting us at 732-605-6353 or filling out the simple form on this page.